Literature DB >> 338141

Malignancy arising in extragonadal endometriosis: a case report and summary of the world literature.

J J Brooks, J E Wheeler.   

Abstract

A case of clear cell carcinoma arising in endometriosis of the retroperitoneum is presented. It occurred 5 years after supracervical hysterectomy and bilateral salpingo-oophorectomy and following 4 years of estrogen therapy. The literature concerning malignancy developing in extragonadal endometriosis has been reviewed and is summarized as follows: 1) 45 cases have been compiled, of which 32 were carcinomas and 13 sarcomas; 2) adenocarcinoma was the most common histologic type, although virtually every tumor of müllerian derivation has been described; 3) the typical patient was nulliparous and perimenopausal; 4) the rectovaginal septum was the most common site, and in general the frequency of malignancy in a given site parallels the frequency of endometriosis in that location; 5) simultaneous tumors of the uterus or ovary were present in seven cases (15%); 6) prognosis appeared affected by site and histologic type; 7) a history of prior pelvic irradiation to effect castration was present in three (9%) of the patients with adenocarcinoma; and 8) four (12%) of the patients with adenocarcinoma were subjected to exogenous estrogens or estrogen-secreting ovarian tumors.

Entities:  

Mesh:

Year:  1977        PMID: 338141     DOI: 10.1002/1097-0142(197712)40:6<3065::aid-cncr2820400645>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  When recurrent genital sores are not genital herpes.

Authors:  H Maiti; M Al-Izzi
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

Review 2.  Malignant transformation of persistent endometriosis after hysterectomy.

Authors:  Naif A Bawazeer; Hatim M Al-Jifree; Abdulrahim M Gari
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

3.  National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; R-L De Wilde; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-12       Impact factor: 2.915

Review 4.  Endometriosis. An important condition in clinical gastroenterology.

Authors:  F R Zwas; D T Lyon
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

5.  Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis: Short Version - AWMF Registry No. 015-045, August 2013.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

6.  The pathology of endometriosis.

Authors:  H Fox
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

7.  Endometrioid adenocarcinoma presenting in a patient 18 years after hysterectomy: a potential hazard of unopposed oestrogen therapy.

Authors:  Alvaro Bedoya Ronga; Salim K Najia; Neil Sahasrabudhe; Richard Prescott; Felicia Elena Buruiana; Alexander Heazell
Journal:  BMJ Case Rep       Date:  2009-08-13

8.  Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis.

Authors:  H Bayramoğlu; E Düzcan
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

9.  Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix: a case report.

Authors:  Han Moie Park; Sang Soo Lee; Dae Woon Eom; Gil Hyun Kang; Sang Wook Yi; Woo Seok Sohn
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

10.  MR imaging findings of extraovarian endocervical mucinous borderline tumors arising from pelvic endometriosis.

Authors:  Dong Myung Yeo; Sung Eun Rha; Jae Young Byun; Ahwon Lee; Mee-Ran Kim
Journal:  Korean J Radiol       Date:  2013-11-05       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.